Clinical Trial Update: Addition of Everolimus to Standard of Care in Carcinoma Gallbladder [Phase 2, Phase 3]

View source ↗

Summary

This document describes a clinical trial evaluating the addition of everolimus to standard of care for gallbladder cancer, across Phase 2 and Phase 3, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Banaras Hindu University | Conditions: Gallbladder Cancer | Phase 2, Phase 3 | Status: RECRUITING